CN103100075A

CN103100075A - Medicament for treating eczema

Info

Publication number: CN103100075A
Application number: CN2013100638164A
Authority: CN
Inventors: 孔涛
Original assignee: Individual
Current assignee: Individual
Priority date: 2013-03-01
Filing date: 2013-03-01
Publication date: 2013-05-15
Anticipated expiration: 2033-03-01
Also published as: CN103100075B

Abstract

The invention relates to a medicament for treating eczema. The medicament is prepared from the following substances in parts by weight: 5-10 parts of figwort root, 10-20 parts of dried ginger, 20-30 parts of dogwood fruit, 10-20 parts of balloonflower root, 15-25 parts of dahurian angelica root, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of dutchmanspipe vine, 10-20 parts of ledebouriella root, 15-30 parts of herba ephedrae, 20-30 parts of belleric terminalia fruit, 1-20 parts of morinda root, 1-20 parts of barbat skullcap, 10-25 parts of cogongrass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of natural indigo, 10-20 parts of giant knotweed, 15-20 parts of herba inulae, 15-30 parts of glabrous sarcandra herb, 10-20 parts of clinopodium polycephalum, 10-25 parts of senna leaf, 5-15 parts of aleppo avens, 1-20 parts of radix rhapontici, 15-25 parts of dahurian rhododendron leaf, 15-25 parts of potentilla discolor, 10-20 parts of calyx seu fructus physalis, 15-25 parts of mulberry bark, 20-30 parts of lindley eupatorium, 1-20 parts of blackberrylily rhizome and 10-25 parts of rhododendron molle. According to the medicament for treating eczema, disclosed by the invention, all ingredients are natural materials, the safety performance is better, and the curative effect is clear, so that the medicament is suitable for being clinically popularized in a large scale.

Description

A kind of medicament for the treatment of eczema

Technical field

The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of eczema.

Background technology

Eczema (eczema) is that the inflammatory skin of a kind of common epidermis that is caused by multiple internal and external factor and high dermis is sick, and it is generally acknowledged with allergy has certain relation.Its clinical manifestation has the characteristics such as symmetry, exudative, itching skin disease, pleomorphism and recurrent.Eczema is a kind of dermatosis of easy recurrence, treatment needs the recurrent medicine dedicated, as contain the medicine of the clean skin composition of health, be also a kind of allergic inflammation dermatoses with the erythra multiformity, the chronic feature that is is shown effect, easily developed into to symmetrical, violent pruritus repeatedly.Can betide any position of any age, but recur or aggravate the winter of being everlasting, the tendency of oozing out be arranged any season, the chronic course of disease, easily outbreak repeatedly.

Summary of the invention

The purpose of this invention is to provide a kind of medicament for the treatment of eczema.

in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of eczema, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Rhizoma Belamcandae 1-20 part and Flos Rhododendri Mollis 10-25 part.

preferably, the medicament for the treatment of eczema of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Scutellariae Barbataes, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 17 parts of Rhizoma Polygoni Cuspidati, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Rhizoma Belamcandae and Flos Rhododendri Mollis.

More preferably, described medicament can be tablet, dispersible tablet, capsule or ointment.

Whole compositions of the medicament for the treatment of eczema of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.

The specific embodiment

Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.

Embodiment ointment of the present invention

take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Scutellariae Barbatae 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Indigo Naturalis 16 grams, Rhizoma Polygoni Cuspidati 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Rhizoma Belamcandae 16 grams and Flos Rhododendri Mollis 24 grams, micronization is pulverized, cross 100 mesh sieves, mix homogeneously.Add liquid paraffin 200 grams and vaseline 350 grams in the powder of above-mentioned mixing, be stirred to and be even paste, and get final product.

Experimental example

30 examples all meet the diagnostic criteria of " clinical dermatology " eczema (Zhao debates. clinical dermatology [M]. the 3rd edition. Nanjing: Jiangsu science tech publishing house, 2001.605.).Man's 19 examples, female's 11 examples; Age 22-61 year, average 42.3 years old; The course of disease 3 months-2 years, average 0.6 year; Forethiga eczema 6 examples, the back of the hand section eczema 4 examples, buttocks eczema person 1 example, huckle eczema person 7 examples, legs eczema person 9 examples, dorsal portion eczema 3 examples.Show as skin lesion and be pleomorphism, be apt to occur in face, hands, foot, shank, visible red mottle or dark red mottle, pimple, vesicle, ooze out, rotten to the corn etc., visible pustule, pus crusts during secondary infection, acute pruritus is accompanied vexed, thirsty, constipation, the red tongue yellow fur, slippery and rapid pulse.

Use the ointment of preparation in embodiment 1 to treat for above-mentioned patient, be as the criterion evenly to be applied to the affected part, one day twice, 20 grams were evenly smeared at each every place, take seven days as a course for the treatment of.

Criterion of therapeutical effect

Recovery from illness: erythra all disappears, and only leaves over pigmentation, and the pruritus transference cure is followed up a case by regular visits to not recurrence in 1 year.Produce effects: erythra obviously disappears or major part disappears, and pruritus obviously alleviates, and even in 1 year have recurrence, but symptom is slight, and skin lesion is front the minimizing.Effectively: erythra partly disappears, and symptom takes a turn for the better, and slight pruritus is arranged.Invalid: erythra is without disappearing or sx↑.

30 routine patients erythra after treating 1 course for the treatment of all disappears, and only leaves over pigmentation, the pruritus transference cure.Follow up a case by regular visits to not recurrence in 1 year.Therefore all meet the recovery from illness standard.

Claims

1. medicament for the treatment of eczema, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Scutellariae Barbatae 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Indigo Naturalis 15-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Rhizoma Belamcandae 1-20 part and Flos Rhododendri Mollis 10-25 part.

2. the medicament for the treatment of eczema according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Scutellariae Barbataes, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Indigo Naturaliss, 17 parts of Rhizoma Polygoni Cuspidati, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Rhizoma Belamcandae and Flos Rhododendri Mollis.

3. the medicament for the treatment of eczema according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or ointment.